AvePoint [AVPTW] vs Oracle [ORCL] Detailed Stock Comparison
AvePoint
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: AvePoint wins in 9 metrics, Oracle wins in 7 metrics, with 0 ties. AvePoint appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AvePoint | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 54.06 | N/A |
| Price-to-Book Ratio | 2.91 | 32.20 | AvePoint |
| Debt-to-Equity Ratio | 4.99 | 519.59 | AvePoint |
| PEG Ratio | N/A | 32.77 | N/A |
| EV/EBITDA | 17.59 | 32.24 | AvePoint |
| Profit Margin (TTM) | -6.86% | 21.68% | Oracle |
| Operating Margin (TTM) | 3.53% | 32.48% | Oracle |
| EBITDA Margin (TTM) | 3.53% | 32.48% | Oracle |
| Return on Equity | -8.23% | 82.38% | Oracle |
| Return on Assets (TTM) | 1.69% | 7.26% | Oracle |
| Free Cash Flow (TTM) | $84.64M | $-394.00M | AvePoint |
| Dividend Yield | N/A | 0.81% | N/A |
| 1-Year Return | 221.88% | 67.51% | AvePoint |
| Price-to-Sales Ratio (TTM) | 3.02 | 11.48 | AvePoint |
| Enterprise Value | $725.26M | $757.28B | Oracle |
| EV/Revenue Ratio | 2.19 | 13.19 | AvePoint |
| Gross Profit Margin (TTM) | 74.32% | 70.19% | AvePoint |
| Revenue per Share (TTM) | $2 | $21 | Oracle |
| Earnings per Share (Diluted) | N/A | $4.34 | N/A |
| Beta (Stock Volatility) | 1.34 | 1.43 | AvePoint |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
AvePoint vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AvePoint | -22.56% | -30.22% | -29.64% | 14.44% | -4.10% | -9.17% |
| Oracle | 1.30% | -4.82% | -4.26% | 48.34% | 38.94% | 40.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AvePoint | 221.88% | -63.21% | -56.72% | -56.72% | -56.72% | -56.72% |
| Oracle | 67.51% | 212.34% | 302.83% | 522.42% | 935.81% | 1,707.44% |
Performance & Financial Health Analysis: AvePoint vs Oracle
| Metric | AVPTW | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $999.46M | $659.01B |
| Market Cap Category | Small cap | Mega cap |
| 10 Day Avg. Volume | 38,796 | 10,879,370 |
| 90 Day Avg. Volume | 37,154 | 10,546,587 |
| Last Close | $5.15 | $236.19 |
| 52 Week Range | $3.44 - $8.76 | $118.86 - $260.87 |
| % from 52W High | -41.21% | -9.46% |
| All-Time High | $15.40 (Aug 15, 2022) | $260.87 (Jul 31, 2025) |
| % from All-Time High | -66.56% | -9.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.25% | 0.11% |
| Quarterly Earnings Growth | 0.25% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | -0.07% | 0.22% |
| Operating Margin (TTM) | 0.04% | 0.32% |
| Return on Equity (TTM) | -0.08% | 0.82% |
| Debt to Equity (MRQ) | 4.99 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.77 | $7.29 |
| Cash per Share (MRQ) | $1.73 | $3.99 |
| Operating Cash Flow (TTM) | $81.63M | $20.82B |
| Levered Free Cash Flow (TTM) | $80.95M | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.81% |
| Last 12-Month Dividend | $0.00 | $1.70 |
Valuation & Enterprise Metrics Analysis: AvePoint vs Oracle
| Metric | AVPTW | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 54.06 |
| Forward P/E | N/A | 32.77 |
| PEG Ratio | N/A | 32.77 |
| Price to Sales (TTM) | 3.02 | 11.48 |
| Price to Book (MRQ) | 2.91 | 32.20 |
| Market Capitalization | ||
| Market Capitalization | $999.46M | $659.01B |
| Enterprise Value | $725.26M | $757.28B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.19 | 13.19 |
| Enterprise to EBITDA | 17.59 | 32.24 |
| Risk & Other Metrics | ||
| Beta | 1.34 | 1.43 |
| Book Value per Share (MRQ) | $1.77 | $7.29 |
Financial Statements Comparison: AvePoint vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AVPTW | ORCL |
|---|---|---|
| Revenue/Sales | $93.06M | $15.90B |
| Cost of Goods Sold | $23.90M | $4.74B |
| Gross Profit | $69.17M | $11.16B |
| Research & Development | $12.69M | $2.65B |
| Operating Income (EBIT) | $3.29M | $5.19B |
| EBITDA | $2.72M | $7.00B |
| Pre-Tax Income | $4.87M | $4.15B |
| Income Tax | $1.31M | $725.00M |
| Net Income (Profit) | $3.57M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AVPTW | ORCL |
|---|---|---|
| Cash & Equivalents | $351.48M | $10.79B |
| Total Current Assets | $446.64M | $24.58B |
| Total Current Liabilities | $208.21M | $32.64B |
| Long-Term Debt | $11.65M | $96.83B |
| Total Shareholders Equity | $361.45M | $20.97B |
| Retained Earnings | $-515.47M | $-15.48B |
| Property, Plant & Equipment | $23.77M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AVPTW | ORCL |
|---|---|---|
| Operating Cash Flow | $-1.94M | $5.93B |
| Capital Expenditures | $-1.51M | N/A |
| Free Cash Flow | $-1.47M | $-2.92B |
| Debt Repayment | $-2,000 | $-6.07B |
| Common Stock Repurchase | $-11.91M | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | AVPTW | ORCL |
|---|---|---|
| Shares Short | N/A | 20.69M |
| Short Ratio | N/A | 1.58 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 38,796 | 10,879,370 |
| Average Daily Volume (90 Day) | 37,154 | 10,546,587 |
| Shares Outstanding | 194.07M | 2.81B |
| Float Shares | 99.59M | 1.64B |
| % Held by Insiders | N/A | 0.42% |
| % Held by Institutions | N/A | 0.45% |
Dividend Analysis & Yield Comparison: AvePoint vs Oracle
| Metric | AVPTW | ORCL |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $1.70 |
| Last 12-Month Dividend Yield | N/A | 0.81% |
| 3-Year Avg Annual Dividend | $0.23 | $1.55 |
| 3-Year Avg Dividend Yield | 3.03% | 0.36% |
| 3-Year Total Dividends | $0.70 | $4.66 |
| Ex-Dividend Date | Sep 29, 2022 | Apr 10, 2025 |